Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent~* Males and females ages 18-69 who are of Hispanic origin~* Symptoms of GERD, defined as heartburn at least 2 times a week on average over the last 3 months~Exclusion Criteria:~* Female patients who are pregnant or breastfeeding~* Known intolerance or lack of response to Proton Pump Inhibitors (PPIs) such as Nexium, Prevacid, or Protonix~* Current or relevant history of non-healed ulcers, stomach surgery, or esophageal surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).